サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1293919

NGSサンプル調製の世界市場：製品別（試薬・消耗品、ワークステーション）、ワークフロー別（DNA、ライブラリー調製、品質管理）、技術別、用途別、エンドユーザー別 - 2023年～2030年の予測

NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (DNA, Library Preparation, Quality Control), Technology, Application, End-User - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
NGSサンプル調製の世界市場：製品別（試薬・消耗品、ワークステーション）、ワークフロー別（DNA、ライブラリー調製、品質管理）、技術別、用途別、エンドユーザー別 - 2023年～2030年の予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のNGSサンプル調製の市場規模は、2023年にCAGR15.93%で24億706万米ドルとなり、2030年までに68億776万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のNGSサンプル調製市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.NGSサンプル調製の世界市場規模および予測は？

2.予測期間中、NGSサンプル調製の世界市場を形成するCOVID-19の阻害要因と影響は？

3.NGSサンプル調製の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.NGSサンプル調製の世界市場における競争戦略は？

5.NGSサンプル調製の世界市場における技術動向と規制の枠組みは？

6.NGSサンプル調製の世界市場における主要ベンダーの市場シェアは？

7.NGSサンプル調製の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症の蔓延と早期診断の必要性の高まり
      • 新しい治療法の研究開発のためのNGSへの有利な投資情勢
      • 持続可能な生産性を実現する農業におけるNGSシーケンス技術の新たな利用
    • 抑制要因
      • NGSサンプル調製プラットフォームの高コストとNGSサンプル調製中の汚染の問題
    • 機会
      • NGSサンプル調製プラットフォームの技術の進歩
      • NGSサンプル調製プラットフォームを開発するための民間組織と政府組織間の協力とパートナーシップの強化
    • 課題
      • 中小規模の研究所では熟練した専門家の人材が限られている
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 NGSサンプル調製市場：製品別

  • 試薬と消耗品
  • ワークステーション

第7章 NGSサンプル調製市場：ワークフロー別

  • DNA
    • ヒト全ゲノム解読（WGS）
    • ターゲットシーケンシング
    • 全エクソームシーケンシング（WES）
  • ライブラリ調整
  • 品質管理
  • RNA
    • 遺伝子発現解析
    • 全トランスクリプトームシーケンス
  • ターゲットの強化
    • ターゲットシーケンス
    • 全エクソームシーケンシング（WES）

第8章 NGSサンプル調製市場：技術別

  • イオン半導体シーケンス
  • ナノポアシーケンシング
  • 合成別配列決定（SBS）
  • 単一分子リアルタイム（SMRT）シーケンシング

第9章 NGSサンプル調製市場：用途別

  • 農業および動物の調査
  • 病気の診断
    • がん診断
    • 感染症の診断
    • リプロダクティブヘルス診断
  • 創薬

第10章 NGSサンプル調製市場：エンドユーザー別

  • 学術機関および研究センター
  • 病院とクリニック
  • 製薬およびバイオテクノロジー企業

第11章 南北アメリカのNGSサンプル調製市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域のNGSサンプル調製市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのNGSサンプル調製市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化

第15章 掲載企業一覧

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NGS SAMPLE PREPARATION MARKET RESEARCH PROCESS
  • FIGURE 2. NGS SAMPLE PREPARATION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2022 VS 2030 (%)
  • FIGURE 6. NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 7. NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 9. NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. NGS SAMPLE PREPARATION MARKET DYNAMICS
  • FIGURE 11. NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. NGS SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. NGS SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NGS SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. NGS SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. NGS SAMPLE PREPARATION MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 8. NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 9. NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NGS SAMPLE PREPARATION MARKET SIZE, BY HUMAN WHOLE GENOME SEQUENCING (WGS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE EXOME SEQUENCING (WES), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NGS SAMPLE PREPARATION MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 16. NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NGS SAMPLE PREPARATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 20. NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQ, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NGS SAMPLE PREPARATION MARKET SIZE, BY WES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE EXOME SEQUENCING (WES), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. NGS SAMPLE PREPARATION MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NGS SAMPLE PREPARATION MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NGS SAMPLE PREPARATION MARKET SIZE, BY SEQUENCING BY SYNTHESIS (SBS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. NGS SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 32. NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NGS SAMPLE PREPARATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. NGS SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. NGS SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. NGS SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. NGS SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. NGS SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 324. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 326. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 333. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 334. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 335. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 342. SAUDI ARABIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 343. SAUDI ARABIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 344. SAUDI ARABIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 345. SAUDI ARABIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018
目次
Product Code: MRR-9F52358C4188

The Global NGS Sample Preparation Market is forecasted to grow significantly, with a projected USD 2,407.06 million in 2023 at a CAGR of 15.93% and expected to reach a staggering USD 6,807.76 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global NGS Sample Preparation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global NGS Sample Preparation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Reagents & Consumables and Workstations. The Reagents & Consumables commanded largest market share of 64.72% in 2022, followed by Workstations.

Based on Workflow, market is studied across DNA, Library Preparation, Quality Control, RNA, and Target Enrichment. The DNA is further studied across Human Whole Genome Sequencing (WGS), Targeted Sequencing, and Whole Exome Sequencing (WES). The RNA is further studied across Gene Expression Analysis and Whole Transcriptome Sequencing. The Target Enrichment is further studied across Targeted Seq, WES, and Whole Exome Sequencing (WES). The DNA commanded largest market share of 24.92% in 2022, followed by RNA.

Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing by Synthesis (SBS), and Single-molecule real-time (SMRT) Sequencing. The Ion Semiconductor Sequencing commanded largest market share of 30.57% in 2022, followed by Single-molecule real-time (SMRT) Sequencing.

Based on Application, market is studied across Agricultural & Animal Research, Disease Diagnostics, and Drug Discovery. The Disease Diagnostics is further studied across Cancer Diagnostics, Infectious Disease Diagnostics, and Reproductive Health Diagnostics. The Drug Discovery commanded largest market share of 39.94% in 2022, followed by Disease Diagnostics.

Based on End-User, market is studied across Academic Institutes and Research Centers, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies commanded largest market share of 49.04% in 2022, followed by Hospitals & Clinics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.81% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global NGS Sample Preparation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global NGS Sample Preparation Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global NGS Sample Preparation Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global NGS Sample Preparation Market?

4. What is the competitive strategic window for opportunities in the Global NGS Sample Preparation Market?

5. What are the technology trends and regulatory frameworks in the Global NGS Sample Preparation Market?

6. What is the market share of the leading vendors in the Global NGS Sample Preparation Market?

7. What modes and strategic moves are considered suitable for entering the Global NGS Sample Preparation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. NGS Sample Preparation Market, by Product, 2022 vs 2030
  • 4.3. NGS Sample Preparation Market, by Workflow, 2022 vs 2030
  • 4.4. NGS Sample Preparation Market, by Technology, 2022 vs 2030
  • 4.5. NGS Sample Preparation Market, by Application, 2022 vs 2030
  • 4.6. NGS Sample Preparation Market, by End-User, 2022 vs 2030
  • 4.7. NGS Sample Preparation Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases and rising need for early disease diagnosis
      • 5.1.1.2. Favorable investment landscape in NGS for the research and development of new treatments
      • 5.1.1.3. Emerging use of NGS sequencing technology in agriculture for sustainable productivity
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in NGS sample preparation platforms
      • 5.1.3.2. Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled professionals in medium and small size laboratories
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. NGS Sample Preparation Market, by Product

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Workstations

7. NGS Sample Preparation Market, by Workflow

  • 7.1. Introduction
  • 7.2. DNA
    • 7.2.1. Human Whole Genome Sequencing (WGS)
    • 7.2.2. Targeted Sequencing
    • 7.2.3. Whole Exome Sequencing (WES)
  • 7.3. Library Preparation
  • 7.4. Quality Control
  • 7.5. RNA
    • 7.5.1. Gene Expression Analysis
    • 7.5.2. Whole Transcriptome Sequencing
  • 7.6. Target Enrichment
    • 7.6.1. Targeted Seq
    • 7.6.2. WES
    • 7.6.3. Whole Exome Sequencing (WES)

8. NGS Sample Preparation Market, by Technology

  • 8.1. Introduction
  • 8.2. Ion Semiconductor Sequencing
  • 8.3. Nanopore Sequencing
  • 8.4. Sequencing by Synthesis (SBS)
  • 8.5. Single-molecule real-time (SMRT) Sequencing

9. NGS Sample Preparation Market, by Application

  • 9.1. Introduction
  • 9.2. Agricultural & Animal Research
  • 9.3. Disease Diagnostics
    • 9.3.1. Cancer Diagnostics
    • 9.3.2. Infectious Disease Diagnostics
    • 9.3.3. Reproductive Health Diagnostics
  • 9.4. Drug Discovery

10. NGS Sample Preparation Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Institutes and Research Centers
  • 10.3. Hospitals & Clinics
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas NGS Sample Preparation Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific NGS Sample Preparation Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa NGS Sample Preparation Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. INTEGRA Biosciences Acquires Miroculus
      • 14.3.1.2. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies
      • 14.3.1.3. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. Ultima Genomics Partners with New England Biolabs to Expand Research Applications on Ultima Sequencers
      • 14.3.2.2. Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System
    • 14.3.3. New Product Launch & Enhancement
      • 14.3.3.1. Agilent enhances user experience in NGS sample preparation workflow
      • 14.3.3.2. Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox
      • 14.3.3.3. NGS KAPA Target Enrichment Product Launch
      • 14.3.3.4. PerkinElmer Launches BioQule NGS System to Automate Library Preparation
      • 14.3.3.5. Introducing Tecan's MagicPrep NGS - the walkaway solution for your NGS library prep needs

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

1. Agilent Technologies, Inc.

2. Applied Biological Materials Inc.

3. Aurora Biomed Inc.

4. Beckman Coulter by Danaher Corporation

5. BGI Group

6. Bio-Rad Laboratories, Inc.

7. BioDynami

8. Eppendorf SE

9. Eurofins Genomics LLC

10. F. Hoffmann-La Roche Ltd.

11. FORMULATRIX, Inc.

12. Illumina, Inc.

13. Integrated DNA Technologies, Inc.

14. Macrogen Inc.

15. Magen Biotechnology Co., Ltd.

16. MCLAB

17. Merck KGaA

18. New England Biolabs, Inc.

19. Novogene Co., Ltd.

20. Oxford Nanopore Technologies PLC

21. PerkinElmer Inc.

22. Promega Corporation

23. Psomagen, Inc.

24. Qiagen N.V.

25. SPT Labtech Ltd

26. Standard BioTools Inc.

27. Sysmex Corporation

28. Takara Bio Inc.

29. Tecan Trading AG

30. Thermo Fisher Scientific Inc.

31. Twist Bioscience Corporation

32. Zymo Research Corporation